Canada's research hotspot gets Cdn$122 million biopharma strategy
This article was originally published in Scrip
Executive Summary
Canada's R&D hotspot, Québec has been given Cdn$122.8 million ($117.6 million) by the Québec government over three years following the unveiling of its biopharmaceutical strategy. The provincial government's measures, which include a high-level forum involving industry and the government representatives, will help the biotech sector, which has been struggling to raise capital this year.